WednesdayJan 10, 2024 4:06 pm

Exploring How Psilocybin Affects Self-Perception

Researchers from Montclair State University recently dived into multitudes of social media posts to try and understand how psilocybin, the main psychedelic element within magic mushrooms, affects an individual’s self-perception. Published in the “Journal of Psychedelic Studies,” the recent study sought to understand how psychedelics, specifically psilocybin, affect self-perception and self-recognition. Psychedelics such as psilocybin have attracted considerable attention in recent years, thanks to a growing body of scientific studies and anecdotal reports of their efficacy against a myriad of mental conditions.  Scientific literature on psychedelics states that they can treat the symptoms of debilitating mental disorders, including post-traumatic stress…

Continue Reading

TuesdayJan 09, 2024 3:12 pm

New Study Suggests Ibogaine Banishes PTSD

A small clinical trial involving military veterans suggests that a psychedelic called ibogaine has the potential to treat traumatic brain injury (TBI) symptoms such as depression and post-traumatic stress disorder (PTSD). The Stanford University study found that the lesser-known psychedelic reduced depression and PTSD symptoms by more than 80% in veterans with TBIs. While the past few years have seen a surge of psychedelic-related studies and clinical trials, most of them have focused on classic psychedelics such as psilocybin (magic mushrooms), MDMA and LSD. These studies found that these popular psychedelics can be effective at treating the symptoms of various…

Continue Reading

FridayJan 05, 2024 2:00 pm

An Analysis of Recent FDA Warnings About Compounded Ketamine

The U.S. Food and Drug Administration (FDA) issued two warnings regarding compounded ketamine use on Feb. 16, 2022, and a year and a half later on Oct. 10, 2023. Ketamine is a dissociative anesthetic that is typically used to induce loss of consciousness and treat pain in both humans and animals. It has some hallucinogenic properties and is often called a dissociative anesthetic hallucinogen because it can make patients and recreational users feel detached from physical pain and the environment. Ketamine can also induce amnesia, a sense of sedation and immobility, making it the drug of choice for bad actors…

Continue Reading

ThursdayJan 04, 2024 3:10 pm

2023 Saw Major Steps Forward for Psychedelic Reform at Both Federal, State Level

Last year was a significant year for psychedelic reform. While researchers worked hard to expand their understanding of psychedelics, several lawmakers strove to advance psychedelic reform policy at the local, state and federal levels. The result was historic psychedelic policy-related advancements throughout the year that further enabled psychedelic research and opened the door to the potential development of alternative mental health treatments. This includes the first-ever federal legislation mandating psychedelic drug-clinical trials, a novel congressional hearing, guidance from the U.S. Food and Drug Administration (FDA) on researching entheogenic substances, the launch of psilocybin services in Oregon and the chance to…

Continue Reading

WednesdayJan 03, 2024 11:47 am

How Psychedelics Are Shaping Modern Technology

After decades of prohibition hindered any meaningful research into their potential risks and benefits, psychedelics are now attracting considerable interest from the scientific community. Multiple studies have found that classic psychedelics such as LSD, MDMA and psilocybin (magic mushrooms) can alleviate the symptoms of several hard-to-treat mental disorders. Combining psychedelic treatment with talk therapy makes the novel treatment much more effective and allows patients to gain long-term relief from minimal psychedelic doses with barely any side effects. Although current research efforts are expanding the scientific community's knowledge of psychedelics significantly, researchers first began studying hallucinogenic drugs several decades ago. In…

Continue Reading

TuesdayJan 02, 2024 1:54 pm

USask Scientists Explore Hidden History of Psychedelics

Researchers from the University of Saskatchewan (USask) are exploring the hidden history of psychedelic drugs and working to expand the world’s clinical and cultural understanding of hallucinogens. Most of the public is unaware of the rich history of psychedelics, let alone their potential medical benefits, and Dr. Erica Dyck from USask is looking to fill this critical knowledge gap by cataloging essays and research into a book. A recent resurgence in psychedelic-related research has found that numerous classic psychedelics can treat debilitating mental disorders with few side effects. Studies have found that psychedelic-based treatments can offer long-term relief against mental…

Continue Reading

FridayDec 29, 2023 1:00 pm

Research Suggests Psilocybin Group Therapy Holds Promise for Treating Depressed Cancer Patients

A study published in the American Cancer Society’s peer-reviewed “CANCER” journal has revealed that psilocybin-assisted group therapy may help treat depression in cancer patients. Psilocybin is one of several classic psychedelics that have been subject to extensive research in recent years due to claims of medical efficacy. Study author and Sunstone Therapies cofounder and chief executive officer Manish Agrawal conducted the study to find suitable ways of addressing the immense emotional and mental distress that often accompanies a cancer diagnosis. Past research has found that hallucinogens such as psilocybin, LSD and MDMA, may be effective at offering long-term relief against…

Continue Reading

ThursdayDec 28, 2023 12:51 pm

Biden Enacts Defense Bill Mandating Studies on Psychedelics for Military Personnel

Last week, President Joe Biden signed a defense bill containing provisions to finance trials into the therapeutic potential for psychedelics for military services members in active duty. This came a week after Congress gave its final approval and forwarded the bill to the president’s desk. The bill requires the defense department to create a process by which military service members with traumatic brain injuries or post-traumatic stress disorder could take part in clinical trials involving MDMA, psilocybin, 5-MeO-DMT and ibogaine. This list also includes eligible plant-based alternative treatments. The U.S. Department of Defense has been given 180 days within which…

Continue Reading

WednesdayDec 27, 2023 3:41 pm

Scientists Design Trip-Free Psychedelic Treatments That Could Accelerate Mental-Health Research

Researchers have developed a potentially “trip-free” psychedelic that could accelerate research efforts to develop psychedelic-based treatments for mental health. The research focused on a critical part of taking hallucinogens — the psychedelic experience — and whether psychedelics can still be effective at treating mental-health conditions if the psychedelic experience, or “trip,” is eliminated. Prior research has found that these experiences can be instrumental in helping patients confront painful, uncomfortable memories, and help them gain life-changing insights and realizations. The “therapy” part of psychedelic-assisted therapy is designed to help people explore the feelings they experienced while under the influence of a…

Continue Reading

TuesdayDec 26, 2023 12:17 pm

Five Ways to Experience Psychedelics Legally

The use of psychedelics has grown significantly these past few years as more data on the substances’ health benefits is revealed in studies. Given that the drugs are still illegal in most parts of the country, it is important to find ways to consume them legally. Below, we look at lawful ways one can undergo a psychedelic experience. Psychedelic retreats These retreats provide individuals with supportive and safe environments for psychedelic exploration using drugs such as ayahuasca, psilocybin, ibogaine and 5-MeO-DMT in countries where these substances are legal or not regulated, including Mexico and Jamaica. Psychedelic retreats offer spaces to…

Continue Reading

PsychedelicNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050